45S5-bioglass®-Based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay

Tissue Engineering - Part A

Volumn 19, Issue 23-24, 2013, Pages 2703-2712

  Handel, Marina ^a   Hammer, Timo R ^a   Nooeaid, Patcharakamon ^b   Boccaccini, Aldo R ^b   Hoefer, Dirk ^a  

^a Hohenstein Institutes   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; CAMS; CELL CULTURE; ENDOTHELIAL CELLS; POLYPROPYLENES; STEM CELLS; THREE DIMENSIONAL; TISSUE; TUBES (COMPONENTS);

BIOLOGICALLY INERT; CHORIO-ALLANTOIC MEMBRANES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; REGENERATIVE MEDICINE; SCAFFOLD MATERIALS; SEMI-QUANTITATIVE ANALYSIS; TISSUE ENGINEERING APPLICATIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

SCAFFOLDS (BIOLOGY);

BIOACTIVE GLASS; COLLAGEN; GLASS; POLYPROPYLENE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED STEM CELL; ANGIOGENESIS ASSAY; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CHORIOALLANTOIS; FIBROBLAST; HEN; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; STEM CELL; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ADIPOSE TISSUE; CELL LINE; CERAMICS; GLASS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84889793169     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0707     Document Type: Article

References (45)

1. Guarino, V.,Causa, F., andAmbrosio, L. Bioactive scaffolds for bone and ligament tissue. Expert RevMed Devices 4, 405, 2007.
2. Hutmacher, D.W., Schantz, J.T., Lam, C.X., Tan, K.C., and Lim, T.C. State of the art and future directions of scaffoldbased bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 1, 245, 2007.
3. Lovett, M., Lee, K., Edwards, A., and Kaplan, D.L. Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 15, 353, 2009.
4. Ghanaati, S., Unger, R.E., Webber, M.J., Barbeck, M., Orth, C., Kirkpatrick, J.A., et al. Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells. Biomaterials 32, 8150, 2011.
5. Hench, L.L. Bioceramics and the origin of life. J Biomed Mater Res 23, 685, 1989.
6. Hoppe, A., Guldal, N.S., and Boccaccini, A.R. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 32, 2757, 2011.
7. Xynos, I.D., Edgar, A.J., Buttery, L.D., Hench, L.L., and Polak, J.M. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass-45S5 dissolution. J Biomed Mater Res 55, 151, 2001.
8. Chen, Q.Z., Efthymiou, A., Salih, V., and Boccaccini, A.R. Bioglass-derived glass-ceramic scaffolds: study of cell proliferation and scaffold degradation in vitro. J Biomed Mater Res A 84, 1049, 2008.
9. Chen, Q.Z., Thompson, I.D., and Boccaccini, A.R. 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials 27, 2414, 2006.
10. Day, R.M. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng 11, 768, 2005.
11. Day, R.M., Boccaccini, A.R., Shurey, S., Roether, J.A., Forbes, A., Hench, L.L., et al. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials 25, 5857, 2004.
12. Leach, J.K., Kaigler, D., Wang, Z., Krebsbach, P.H., and Mooney, D.J. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27, 3249, 2006.
13. Leu, A., and Leach, J.K. Proangiogenic potential of a collagen/bioactive glass substrate. Pharm Res 25, 1222, 2008.
14. Deb, S., Mandegaran, R., and Di Silvio, L. A porous scaffold for bone tissue engineering/45S5 Bioglass-derived porous scaffolds for co-culturing osteoblasts and endothelial cells. J Mater Sci Mater Med 21, 893, 2010.
15. Gerhardt, L.C., Widdows, K.L., Erol, M.M., Burch, C.W., Sanz-Herrera, J.A., Ochoa, I., et al. The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds. Biomaterials 32, 4096, 2011.
16. Gorustovich, A.A., Roether, J.A., and Boccaccini, A.R. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev 16, 199, 2010.
17. Gorustovich, A.A., Vargas, G.E., Bretcanu, O., Mesones, R.V., Porto Lopez, J.M., and Boccaccini, A.R. Novel bioassay to evaluate biocompatibility of bioactive glass scaffolds for tissue engineering. Adv Appl Ceram 107, 274, 2008.
18. Vargas, G.E., Mesones, R.V., Bretcanu, O., Lopez, J.M., Boccaccini, A.R., and Gorustovich, A. Biocompatibility and bone mineralization potential of 45S5 Bioglass-derived glassceramic scaffolds in chick embryos. Acta Biomater 5, 374, 2009.
19. Ghosh, S.K., Nandi, S.K., Kundu, B., Datta, S., De, D.K., Roy, S.K., et al. In vivo response of porous hydroxyapatite and beta-tricalcium phosphate prepared by aqueous solution combustion method and comparison with bioglass scaffolds. J Biomed Mater Res B Appl Biomater 86, 217, 2008.
20. Nandi, S.K., Kundu, B., Datta, S., De, D.K., and Basu, D. The repair of segmental bone defects with porous bioglass: an experimental study in goat. Res Vet Sci 86, 162, 2009.
21. Ross, E.A., Batich, C.D., Clapp, W.L., Sallustio, J.E., and Lee, N.C. Tissue adhesion to bioactive glass-coated silicone tubing in a rat model of peritoneal dialysis catheters and catheter tunnels. Kidney Int 63, 702, 2003.
22. Auerbach, R., Akhtar, N., Lewis, R.L., and Shinners, B.L. Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev 19, 167, 2000.
23. Ribatti, D. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol 270, 181, 2008.
24. Ribatti, D., Nico, B., Vacca, A., Roncali, L., Burri, P.H., and Djonov, V. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 264, 317, 2001.
25. Ribatti, D., and Presta, M. The role of fibroblast growth factor-2 in the vascularization of the chick embryo chorioallantoic membrane. J Cell Mol Med 6, 439, 2002.
26. Ribatti, D., Nico, B., Morbidelli, L., Donnini, S., Ziche, M., Vacca, A., et al. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. J Vasc Res 38, 389, 2001.
27. Gimble, J.M., Katz, A.J., and Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 100, 1249, 2007.
28. Beckermann, B.M., Kallifatidis, G., Groth, A., Frommhold, D., Apel, A., Mattern, J., et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 99, 622, 2008.
29. Zhou, M., Liu, Z., Liu, C., Jiang, X., Wei, Z., Qiao, W., et al. Tissue engineering of small-diameter vascular grafts by endothelial progenitor cells seeding heparin-coated decellularized scaffolds. J Biomed Mater Res B Appl Biomater 100, 111, 2012.
30. Wu, Y., Chen, L., Scott, P.G., and Tredget, E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25, 2648, 2007.
31. Nagy, J.A., Vasile, E., Feng, D., Sundberg, C., Brown, L.F., Manseau, E.J., et al. VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations. Cold Spring Harb Symp Quant Biol 67, 227, 2002.
32. Handel, M., Hammer, T.R., and Hoefer, D. Adipogenic differentiation of scaffold-bound human adipose tissue-derived stem cells (hASC) for soft tissue engineering. Biomed Mater 7, 054107, 2012.
33. Gimble, J.M., Guilak, F., and Bunnell, B.A. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 1, 19, 2010.
34. Sterodimas, A., de Faria, J., Nicaretta, B., and Pitanguy, I. Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg 63, 1886, 2010.
35. Nakagami, H., Morishita, R., Maeda, K., Kikuchi, Y., Ogihara, T., and Kaneda, Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 13, 77, 2006.
36. Lee, E.Y., Xia, Y., Kim, W.S., Kim, M.H., Kim, T.H., Kim, K.J., et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 17, 540, 2009.
37. Yao, C., Markowicz, M., Pallua, N., Noah, E.M., and Steffens, G. The effect of cross-linking of collagen matrices on their angiogenic capability. Biomaterials 29, 66, 2008.
38. Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. Angiogenesis assays: a critical overview. Clin Chem 49, 32, 2003.
39. Oates, M., Chen, R., Duncan, M., and Hunt, J.A. The angiogenic potential of three-dimensional open porous synthetic matrix materials. Biomaterials 28, 3679, 2007.
40. Ribatti, D., Nico, B., Vacca, A., and Presta, M. The gelatin sponge-chorioallantoicmembrane assay.Nat Protoc 1, 85, 2006.
41. Arnaoutova, I., George, J., Kleinman, H.K., and Benton, G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12, 267, 2009.
42. Xynos, I.D., Edgar, A.J., Buttery, L.D., Hench, L.L., and Polak, J.M. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 276, 461, 2000.
43. Chung, H.M., Won, C.H., and Sung, J.H. Responses of adipose-derived stem cells during hypoxia: enhanced skinregenerative potential. Expert Opin Biol Ther 9, 1499, 2009.
44. Hagedorn, M., Balke, M., Schmidt, A., Bloch, W., Kurz, H., Javerzat, S., et al. VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis. Dev Dyn 230, 23, 2004.
45. Mourino, V., Cattalini, J.P., and Boccaccini, A.R. Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface 9, 401, 2012.